Hereditary Cancer in Clinical Practice Q2
Unclaimed
BioMed Central Ltd
United Kingdom
Hereditary Cancer in Clinical Practice is a journal indexed in SJR in Oncology and Genetics (clinical) with an H index of 31. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 2290 €. The scope of the journal is focused on cancer genetics. It has an SJR impact factor of 0,729 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,729.
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -


Categories:
Oncology (Q2)
Genetics (clinical) (Q3)
Price
2290 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,729
SJR Impact factor31
H Index27
Total Docs (Last Year)107
Total Docs (3 years)963
Total Refs206
Total Cites (3 years)103
Citable Docs (3 years)2
Cites/Doc (2 years)35.67
Ref/DocOther journals with similar parameters
International Journal of Oncology Q2
BMC Cancer Q2
Cancer Epidemiology Q2
Frontiers in Oncology Q2
Journal of Geriatric Oncology Q2
Compare this journals
Aims and Scope
Cancer genetics
Comments